Who owns LAVA THERAPEUTICS NV?
- Ticker: LVTX
- CUSIP Number: n51517105
Tip: Access positions for across all investors
Analyze quarterly positions in Lava Therapeutics Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lava Therapeutics Nv stock
Who bought or sold LAVA THERAPEUTICS NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Redmile Group | 2.1M | $3.4M | 0% | Sep 2024 |
|
| Bruce & Co | 772k | $1.3M | 0% | Sep 2024 |
|
| Sphera Funds Management | 368k | $662k | 0% | Jun 2024 |
|
| Two Sigma Investments | 112k | $202k | 37% | Jun 2024 |
|
| Pathway Financial Advisors | 103k | $170k | 71% | Sep 2024 |
|
| Falcon Edge Capital | 87k | $145k | 0% | Sep 2024 |
|
| Susquehanna International | 74k | $123k | 1% | Sep 2024 |
|
| Pnc Financial Services | 65k | $108k | 0% | Sep 2024 |
|
| Tang Capital Management | 53k | $88k | 939% | Sep 2024 |
|
| Two Sigma Advisers | 32k | $57k | 90% | Jun 2024 |
|
| Citadel Advisors | 24k | $40k | -79% | Sep 2024 |
|
| Virtu Financial | 19k | $32k | 100% | Sep 2024 |
|
| Morgan Stanley | 16k | $28k | 53% | Jun 2024 |
|
| Engineers Gate Manager | 12k | $20k | 100% | Sep 2024 |
|
| Geode Capital Management | 11k | $19k | 0% | Sep 2024 |
|
| Atlantic Trust | 6.0k | $10k | 0% | Sep 2024 |
|
| TSFG | 400.00 | $1.0k | 0% | Sep 2024 |
|
| Simplex Trading | 51.00 | $0 | -77% | Sep 2024 |
|
Who sold out of Lava Therapeutics Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2024 | 31k | $56k |
| Millennium Management | Jun 2024 | 27k | $48k |
| Two Sigma Securities | Mar 2024 | 13k | $43k |
| Bank of America Corporation | Jun 2024 | 400.00 | $720.000000 |